反应详情

N-Bromosuccinimide (0.104 g, 0.585 mmol) was added to a solution of 4-(3,5, -dichloropyridin-4-ylamino)-8-(cyclopentyloxy)-7-methoxyquinolin-2(1H)-one (0.246 g, 0.585 mmol, Example 1) and anhydrous dimethylformamide (3 mL) at 0° C. After 4 h at 0° C., the mixture was poured into water, and the precipitate was filtered. Saturated sodium thiosulfate solution (1 mL) was added to a solution of the filter cake and methanol (5 mL). After the dibromo intermediate was consumed, as monitored by LCMS, the mixture was diluted with water and extracted with ethyl acetate. The organic extract was dried, filtered, and concentrated to give 3-bromo-8-(cyclopentyloxy)-4-(3,5-dichloropyridin-4-ylamino)-7-methoxyquinolin-2(1H)-one: 1H NMR (400 MHz, DMSO-d6): δ 10.56 (s, 1H), 8.88 (br s, 1H), 8.42 (s, 2H), 7.62 (d, 1H), 7.04 (d, 1H), 4.98 (m, 1H), 3.89 (s, 3H), 1.84-1.51 (m, 8H); MS (ESI): 497.8.

1. filtrationthe precipitate was filtered
2. additionSaturated sodium thiosulfate solution (1 mL) was added to a solution of the filter cake and methanol (5 mL)
3. customAfter the dibromo intermediate was consumed
4. additionthe mixture was diluted with water
5. extractionextracted with ethyl acetate
6. extractionThe organic extract
7. customwas dried
8. filtrationfiltered
9. concentrationconcentrated